7 recruiting, 6 completed, 5 unknown, 1 not yet recruiting. 19 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 19 | Recruiting 7, Completed 6, Unknown 5, Not yet recruiting 1 |
| Phase 2 | 4 | Unknown 3, Recruiting 1 |
Follow Ischemic Stroke, Acute: new trials by email Literature Review of Ischemic Stroke, Acute trials Research Report on Ischemic Stroke, Acute
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion Recombinant Tissue Plasminogen Activator (rt-PA), Intra-arterial Thrombolysis, Best Medical Management - Medium Vessel Occlusion, Ischemic Stroke, Acute | Phase 3 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 372 | 2026-09-19 | 2026-09-23 |
| Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset non-immunogenic staphylokinase, Placebo - Ischemic Stroke, Acute | Phase 3 | Recruiting | Supergene, LLC | 1050 | 2026-06-09 | 2026-11-12 |
| Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke Remote Ischemic Conditioning, Sham Remote Ischemic Conditioning - Ischemic Stroke, Acute, Myocardial Injury | Phase 3 | Not yet recruiting | Capital Medical University | 580 | 2026-05-01 | 2026-04-15 |
| Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) Tegoprazan 50 mg, Placebo - Ischemic Stroke, Ischemic Stroke, Acute | Phase 3 | Recruiting | Hanyang University Guri Hospital | 1524 | 2026-01-26 | 2026-07-08 |
| Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic Stroke Tirofiban Hydrochloride, Standard medical treatment (SMT) - Acute Stroke, Ischemic Stroke, Acute | Phase 2 / Phase 3 | Unknown | Capital Medical University | 302 | 2024-11-20 | 2024-10-29 |
| Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D ) Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit - Ischemic Stroke, Acute | Phase 3 | Unknown | Beijing Tiantan Hospital | 600 | 2024-08-10 | 2024-10-01 |
| Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-C ) Emergency Stroke Unit based on 0.23-T MRI, Standard stroke unit adherent to guidelines - Ischemic Stroke, Acute | Phase 3 | Completed | Beijing Tiantan Hospital | 1622 | 2024-08-08 | 2025-08-22 |
| Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4) Tirofiban, Placebo - Ischemic Stroke, Acute, TIA | Phase 3 | Recruiting | Beijing Tiantan Hospital | 4674 | 2024-07-11 | 2024-07-12 |
| Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke Intra-arterial tenecteplase injection at the completion of thrombectomy, Placebo - Ischemic Stroke, Acute, Cerebrovascular Disorders | Phase 2 / Phase 3 | Recruiting | University of Melbourne | 462 | 2024-06-01 | 2026-05-18 |
| Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke Early Dual Antiplatelet Therapy, Placebo - Ischemic Stroke, Acute | Phase 3 | Completed | Beijing Tiantan Hospital | 1382 | 2024-04-03 | 2026-01-22 |
| Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion Tenecteplase, direct EVT - Ischemic Stroke, Acute, Thrombolysis | Phase 3 | Completed | Beijing Tiantan Hospital | 391 | 2024-01-25 | 2025-11-26 |
| Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5 Tenecteplase, Best Practice (which may include intravenous Alteplase) - Ischemic Stroke, Acute | Phase 3 | Completed | Beijing Tiantan Hospital | 452 | 2024-01-24 | 2025-11-26 |
| Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY) Shuxuening Injection, Placebo - Ischemic Stroke, Acute | Phase 3 | Recruiting | Beijing Tiantan Hospital | 1380 | 2024-01-11 | 2025-07-24 |
| Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke Edaravone Dexborneol Concentrated Solution for injection, Edaravone Dexborneol placebo - Ischemic Stroke, Acute, Treatment Outcome | Phase 3 | Unknown | Xiangya Hospital of Central South University | 212 | 2023-07-01 | 2023-06-27 |
| Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke Minocycline hydrochloride capsule, Placebo capsules of Minocycline hydrochloride capsules - Ischemic Stroke, Acute | Phase 3 | Completed | Beijing Tiantan Hospital | 1724 | 2023-05-19 | 2025-05-14 |
| Analyzing the Pharmacodynamic Substances and the Effects of Yiqihuayu Decotion for Acute Ischemic Stroke (PHYSIS) Yiqihuayu Decotion - Ischemic Stroke, Acute | Phase 2 / Phase 3 | Unknown | Ying Gao | 15 | 2022-09-25 | 2022-09-29 |
| Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT Intravenous tenecteplase, Placebo - Ischemic Stroke, Acute | Phase 3 | Recruiting | Hospital Moinhos de Vento | 466 | 2022-01-20 | 2025-04-04 |
| Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III tenecteplase (0.25 mg/kg, Max 25 mg), standard medical treatment - Ischemic Stroke, Acute | Phase 3 | Completed | Beijing Tiantan Hospital | 516 | 2022-01-19 | 2024-04-30 |
| The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke Ginkgo diterpene lactone meglumine injection, Ginkgo diterpene lactone meglumine injection simulation, Aspirin - Ischemic Stroke, Acute | Phase 2 / Phase 3 | Unknown | Shanghai Yueyang Integrated Medicine Hospital | 80 | 2021-01-01 | 2022-12-29 |
Ischemic Stroke (19) · Cerebrovascular Disorders (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebral Infarction (1) · Gastrointestinal Hemorrhage (1) · Infarction, Middle Cerebral Artery (1) · Ischemic Attack, Transient (1) · Stroke (1) · cyclopia sequence (1)
Cardiovascular Diseases (19) · Nervous System Diseases (19) · Vascular Diseases (19) · Brain Diseases (18) · Central Nervous System Diseases (18) · Stroke (18) · Cerebrovascular Disorders (17) · Brain Ischemia (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Brain Infarction (2) · Infarction (2) · Ischemia (2) · Necrosis (2) · Cerebral Arterial Diseases (1)
Tenecteplase (5) · Aspirin (3) · Tirofiban (2) · Clopidogrel (1) · Injections (1) · MAX protein, human (1) · Minocycline (1) · Practice Guidelines as Topic (1) · TNK-tissue plasminogen activator (1) · Ticagrelor (1) · Tissue Plasminogen Activator (1) · shuxuening (1) · tegoprazan (1)
Beijing Tiantan Hospital (9) · Capital Medical University (2) · Hanyang University Guri Hospital (1) · Hospital Moinhos de Vento (1) · Shanghai Yueyang Integrated Medicine Hospital (1) · Supergene, LLC (1) · The First Affiliated Hospital with Nanjing Medical University (1) · University of Melbourne (1) · Xiangya Hospital of Central South University (1) · Ying Gao (1)
China (13) · Australia (1) · Brazil (1) · New Zealand (1) · Russia (1) · South Korea (1)
Yongjun Wang (2) · Bruce Campbell, MD, PhD (1) · Fana Alemseged, MD, PhD (1) · Fengyuan Che, MD (1) · Gisele Sampaio Silva, MD, MPH, PhD (1) · Nikolay A. Shamalov, MD, prof (1) · Raul G Nogueira, MD (1) · Sergey S. Markin, MD, prof (1) · Sheila CO Martins, MD, PhD (1) · Sheng Liu, Professor (1) · Yan Han, Ph.D. (1) · Yilong Wang, MD, PhD (1) · Yilong Wang, PhD+MD (1) · Yongjun Wang, MD (1) · Yongjun Wang, MD, PhD (1)
PMID 34487721, PMID 11306611, PMID 19628804, PMID 21737808, PMID 21909339, PMID 22632907, PMID 25888869, PMID 26510778, PMID 27673305, PMID 29232823, PMID 29444972, PMID 29601945, PMID 29948247, PMID 30619060, PMID 31263257, PMID 31296369, PMID 31570084, PMID 31610199, PMID 31719236, PMID 31899551, PMID 32374815, PMID 33077917, PMID 33588596, PMID 33879319, PMID 34224187, PMID 34418399, PMID 35233540, PMID 35461991, PMID 36239644, PMID 37247876, PMID 37256974, PMID 38648030, PMID 38884324, PMID 41151803, PMID 41293810, PMID 41611343, PMID 41628627, PMID 41655588, PMID 41815809, PMID 41992212, PMID 42099212, PMID 42114550, PMID 42159994, PMID 42689322